Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.22 USD | -0.17% | -0.47% | -17.41% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.41% | 3.13B | |
+5.77% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-19.85% | 1.38B | |
-30.40% | 1.2B | |
+7.31% | 959M | |
-34.66% | 915M | |
-26.60% | 819M | |
-18.08% | 700M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Transcript : Evolent Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03